188 related articles for article (PubMed ID: 30410336)
1. Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles.
Yang C; Hwang HH; Jeong S; Seo D; Jeong Y; Lee DY; Lee K
Int J Nanomedicine; 2018; 13():6517-6530. PubMed ID: 30410336
[TBL] [Abstract][Full Text] [Related]
2. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
3. Idarubicin-loaded methoxy poly(ethylene glycol)-
Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S
Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113
[TBL] [Abstract][Full Text] [Related]
4. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
5. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
8. Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.
Surwase SS; Munot NM; Idage BB; Idage SB
Drug Deliv Transl Res; 2017 Jun; 7(3):416-427. PubMed ID: 28324320
[TBL] [Abstract][Full Text] [Related]
9. Enhanced NO-induced angiogenesis
Lee J; Yang C; Ahn S; Choi Y; Lee K
Biomater Sci; 2021 Jul; 9(15):5150-5159. PubMed ID: 33949445
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
11. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
12. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
13. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
14. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
15. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
17. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
20. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
[Next] [New Search]